These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18172769)

  • 1. Estimating the differential costs of criminal activity for juvenile drug court participants: challenges and recommendations.
    McCollister KE; French MT; Sheidow AJ; Henggeler SW; Halliday-Boykins CA
    J Behav Health Serv Res; 2009 Jan; 36(1):111-26. PubMed ID: 18172769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Evaluation of the Juvenile Drug Court/Reclaiming Futures (JDC/RF) Model.
    McCollister K; Baumer P; Davis M; Greene A; Stevens S; Dennis M
    J Behav Health Serv Res; 2018 Jul; 45(3):321-339. PubMed ID: 29582233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of multisystemic therapy with serious and violent juvenile offenders.
    Klietz SJ; Borduin CM; Schaeffer CM
    J Fam Psychol; 2010 Oct; 24(5):657-66. PubMed ID: 20954776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of multisystemic therapy with juvenile sexual offenders.
    Borduin CM; Dopp AR
    J Fam Psychol; 2015 Oct; 29(5):687-96. PubMed ID: 26075740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments.
    Henggeler SW; Halliday-Boykins CA; Cunningham PB; Randall J; Shapiro SB; Chapman JE
    J Consult Clin Psychol; 2006 Feb; 74(1):42-54. PubMed ID: 16551142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile drug courts: emerging outcomes and key research issues.
    Henggeler SW
    Curr Opin Psychiatry; 2007 May; 20(3):242-6. PubMed ID: 17415076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unit Costs of Delinquent Acts for Use in Economic Evaluations.
    Reckers-Droog VT; Goorden M; Dijkgraaf MGW; Van Eeren HV; McCollister KE; Hakkaart-van Roijen L
    J Ment Health Policy Econ; 2019 Jun; 22(2):71-79. PubMed ID: 31319377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile crime and criminal justice: resolving border disputes.
    Fagan J
    Future Child; 2008; 18(2):81-118. PubMed ID: 21337999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Impact of the Statewide Implementation of an Evidence-Based Treatment: Multisystemic Therapy in New Mexico.
    Dopp AR; Coen AS; Smith AB; Reno J; Bernstein DH; Kerns SEU; Altschul D
    Behav Ther; 2018 Jul; 49(4):551-566. PubMed ID: 29937257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Money Matters: Cost Effectiveness of Juvenile Drug Court with and without Evidence-Based Treatments.
    Sheidow AJ; Jayawardhana J; Bradford WD; Henggeler SW; Shapiro SB
    J Child Adolesc Subst Abuse; 2012; 21(1):69-90. PubMed ID: 22389577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of multisystemic therapy through midlife: a cost-benefit analysis with serious juvenile offenders and their siblings.
    Dopp AR; Borduin CM; Wagner DV; Sawyer AM
    J Consult Clin Psychol; 2014 Aug; 82(4):694-705. PubMed ID: 24684692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering more effective treatment to adolescents: Improving the juvenile drug court model.
    Belenko S; Logan TK
    J Subst Abuse Treat; 2003 Oct; 25(3):189-211. PubMed ID: 14670524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of family therapy in juvenile drug court.
    Dakof GA; Henderson CE; Rowe CL; Boustani M; Greenbaum PE; Wang W; Hawes S; Linares C; Liddle HA
    J Fam Psychol; 2015 Apr; 29(2):232-41. PubMed ID: 25621927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration.
    Eeren HV; Schawo SJ; Scholte RH; Busschbach JJ; Hakkaart L
    PLoS One; 2015; 10(7):e0131255. PubMed ID: 26146831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile Drug Treatment Court.
    Ledgerwood DM; Cunningham PB
    Pediatr Clin North Am; 2019 Dec; 66(6):1193-1202. PubMed ID: 31679607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders.
    Henggeler SW; Clingempeel WG; Brondino MJ; Pickrel SG
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):868-74. PubMed ID: 12108813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between juvenile offenders with and without substance use problems in the prevalence and impact of risk and protective factors for criminal recidivism.
    van der Put CE; Creemers HE; Hoeve M
    Drug Alcohol Depend; 2014 Jan; 134():267-274. PubMed ID: 24238911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices.
    Henggeler SW; McCart MR; Cunningham PB; Chapman JE
    J Consult Clin Psychol; 2012 Apr; 80(2):264-75. PubMed ID: 22309470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of Juvenile Cases to Criminal Court.
    Lee SJ; Kraus LJ
    Child Adolesc Psychiatr Clin N Am; 2016 Jan; 25(1):41-7. PubMed ID: 26593117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Los Angeles County drug court programs: initial results.
    Fielding JE; Tye G; Ogawa PL; Imam IJ; Long AM
    J Subst Abuse Treat; 2002 Oct; 23(3):217-24. PubMed ID: 12392808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.